United States Biotechnology & Medical Research

Tvardi Therapeutics, Inc. (TVRD)

Ticker: TVRD Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Tvardi Therapeutics, Inc.. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Terrillion Scott SEC'Y; CHIEF COMPLIANCE & G.C. Officer
Transaction date
Planned sale
Price
197.70
Quantity 59,770 +31.7%
Value US$238,006
1.3
Posner Christopher PRESIDENT AND CEO Executive Director
Transaction date
Planned sale
Price
260.90
Quantity 58,638 -10.8%
Value US$4,598,566
1.3
Posner Christopher PRESIDENT AND CEO Executive Director
Transaction date
Planned sale
Price
115.74
Quantity 16,664 +4.0%
Value US$4,735,688
1.3
Posner Christopher PRESIDENT AND CEO Executive Director
Transaction date
Planned sale
Price
0.29
Quantity 3,668 -2.1%
Value US$1,064
1.3
Posner Christopher PRESIDENT AND CEO Executive Director
Transaction date
Planned sale
Price
0.35
Quantity 4,149 -2.3%
Value US$1,452
1.3
Posner Christopher PRESIDENT AND CEO Executive Director
Transaction date
Planned sale
Price
0.75
Quantity 3,936 -2.2%
Value US$2,952
Terrillion Scott SEC'Y; CHIEF COMPLIANCE & G.C. Officer
Transaction date
Planned sale
Price
0.83
Quantity 2,753 -3.0%
Value US$2,285
1.3
Goncalves Joana CHIEF MEDICAL OFFICER Officer
Transaction date
Planned sale
Price
0.83
Quantity 2,753 -4.9%
Value US$2,285
1.3
Posner Christopher PRESIDENT AND CEO Executive Director
Transaction date
Planned sale
Price
0.89
Quantity 5,834 -3.1%
Value US$5,192
Terrillion Scott SEC'Y; CHIEF COMPLIANCE & G.C. Officer
Transaction date
Planned sale
Price
0.89
Quantity 3,293 -3.5%
Value US$2,931
1.3
Goncalves Joana CHIEF MEDICAL OFFICER Officer
Transaction date
Planned sale
Price
0.89
Quantity 3,293 -5.5%
Value US$2,931
1.3
Posner Christopher PRESIDENT AND CEO Executive Director
Transaction date
Planned sale
Price
0.53
Quantity 35,575 -16.0%
Value US$18,855
1.3
Posner Christopher PRESIDENT AND CEO Executive Director
Transaction date
Planned sale
Price
0.55
Quantity 4,981 -2.2%
Value US$2,740
1.3
Posner Christopher President and CEO Executive Director
Transaction date
Planned sale
Price
1.22
Quantity 3,796 -2.3%
Value US$4,631
1.3
Posner Christopher President and CEO Executive Director
Transaction date
Planned sale
Price
3.07
Quantity 4,307 -2.5%
Value US$13,222
Menzaghi Frederique Ph.D. Chief Scientific Off,SVP-R&D Officer
Transaction date
Planned sale
Price
3.51
Quantity 2,993 -1.9%
Value US$10,505
1.3
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
3.51
Quantity 2,723 -4.8%
Value US$9,558
Terrillion Scott Sec'y; Chief Compliance & G.C. Officer
Transaction date
Planned sale
Price
3.51
Quantity 2,483 -2.7%
Value US$8,715
1.3
Posner Christopher President and CEO Executive Director
Transaction date
Planned sale
Price
4.40
Quantity 3,869 -2.2%
Value US$17,024
Terrillion Scott Sec'y; Chief Compliance & G.C. Officer
Transaction date
Planned sale
Price
4.91
Quantity 2,481 -2.7%
Value US$12,182
Menzaghi Frederique Ph.D. Chief Scientific Off,SVP-R&D Officer
Transaction date
Planned sale
Price
4.91
Quantity 2,733 -1.7%
Value US$13,419
1.3
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
4.91
Quantity 2,481 -4.2%
Value US$12,182
Terrillion Scott Sec'y; Chief Compliance & G.C. Officer
Transaction date
Planned sale
Price
9.71
Quantity 6,256 -6.3%
Value US$60,746
1.3
Posner Christopher President and CEO Executive Director
Transaction date
Planned sale
Price
9.71
Quantity 5,987 -3.3%
Value US$58,134
Menzaghi Frederique Ph.D. Chief Scientific Off,SVP-R&D Officer
Transaction date
Planned sale
Price
9.71
Quantity 6,802 -4.1%
Value US$66,047
1.3
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
9.71
Quantity 6,221 -9.6%
Value US$60,406
1.3
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
10.20
Quantity 2,265 -3.4%
Value US$23,103
3.3
Maynard Ryan D CHIEF FINANCIAL OFFICER Officer
Transaction date
Planned sale
Price
0.53
Quantity 5,488 -40.7%
Value US$2,909
1.3
Goncalves Joana CHIEF MEDICAL OFFICER Officer
Transaction date
Planned sale
Price
0.53
Quantity 7,770 -11.6%
Value US$4,118
Terrillion Scott SEC'Y; CHIEF COMPLIANCE & G.C. Officer
Transaction date
Planned sale
Price
0.53
Quantity 7,770 -7.6%
Value US$4,118
1.3
Posner Christopher President and CEO Executive Director
Transaction date
Planned sale
Price
11.80
Quantity 4,191 -2.2%
Value US$49,454
1.3
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
10.81
Quantity 2,265 -3.3%
Value US$24,485
1.3
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
10.18
Quantity 2,265 -3.2%
Value US$23,058
Menzaghi Frederique Ph.D. Chief Scientific Off,SVP-R&D Officer
Transaction date
Planned sale
Price
11.27
Quantity 3,506 -2.1%
Value US$39,513
Terrillion Scott Sec'y; Chief Compliance & G.C. Officer
Transaction date
Planned sale
Price
11.27
Quantity 2,561 -2.5%
Value US$28,862
1.3
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
11.27
Quantity 2,992 -4.0%
Value US$33,720
1.3
Posner Christopher President and CEO Executive Director
Transaction date
Planned sale
Price
11.13
Quantity 14,470 -7.2%
Value US$161,051
2.0
VOGELBAUM MARTIN Non-Executive Director
Transaction date
Sale
Price
10.28
Quantity 10,800 -19.4%
Value US$111,024
BAINS HARRISON M JR Non-Executive Director
Transaction date
Planned sale
Price
9.05
Quantity 7,200 -22.3%
Value US$65,160
3.3
Ives Jeffrey L. Non-Executive Director
Transaction date
Planned sale
Price
9.05
Quantity 3,600 -18.9%
Value US$32,580
1.3
Posner Christopher President and CEO Executive Director
Transaction date
Planned sale
Price
12.67
Quantity 2,006 -1.0%
Value US$25,416
Menzaghi Frederique Ph.D. Chief Scientific Off,SVP-R&D Officer
Transaction date
Planned sale
Price
11.91
Quantity 1,784 -1.0%
Value US$21,247
Terrillion Scott Sec'y; Chief Compliance & G.C. Officer
Transaction date
Planned sale
Price
11.91
Quantity 1,642 -1.6%
Value US$19,556
1.3
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
11.91
Quantity 1,642 -2.1%
Value US$19,556
Terrillion Scott Sec'y; Chief Compliance & G.C. Officer
Transaction date
Planned sale
Price
11.38
Quantity 1,787 -1.7%
Value US$20,336
Reilly Thomas Charles Chief Financial Officer Officer
Transaction date
Planned sale
Price
11.38
Quantity 2,044 -5.1%
Value US$23,261
Terrillion Scott Sec'y; Chief Compliance & G.C. Officer
Transaction date
Planned sale
Price
10.29
Quantity 1,972 -1.9%
Value US$20,292
Menzaghi Frederique Ph.D. Chief Scientific Off,SVP-R&D Officer
Transaction date
Planned sale
Price
10.29
Quantity 2,114 -1.2%
Value US$21,753
1.3
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
10.29
Quantity 1,972 -2.5%
Value US$20,292
3.3
Ives Jeffrey L. Non-Executive Director
Transaction date
Sale
Price
16.04
Quantity 8,180 -53.2%
Value US$131,207
1.3
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
17.15
Quantity 1,000 -2.1%
Value US$17,150
1.3
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
15.00
Quantity 1,000 -2.1%
Value US$15,000
Terrillion Scott Sec'y; Chief Compliance & G.C. Officer
Transaction date
Planned sale
Price
14.20
Quantity 1,759 -2.4%
Value US$24,978
1.3
Posner Christopher Non-Executive Director
Transaction date
Planned sale
Price
13.04
Quantity 2,304 -12.5%
Value US$30,044
2.0
VOGELBAUM MARTIN Non-Executive Director
Transaction date
Planned sale
Price
13.05
Quantity 8,640 -30.0%
Value US$112,752
3.3
Ives Jeffrey L. Non-Executive Director
Transaction date
Planned sale
Price
13.05
Quantity 2,520 -14.1%
Value US$32,886
1.3
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
19.65
Quantity 3,000 -8.9%
Value US$58,950
0.9
CHALMERS DEREK T President & CEO Executive Director
Transaction date
Planned sale
Price
17.98
Quantity 3,103 -0.3%
Value US$55,792
1.3
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
17.98
Quantity 3,093 -8.4%
Value US$55,612
Menzaghi Frederique Ph.D. Chief Scientific Off,SVP-R&D Officer
Transaction date
Planned sale
Price
17.98
Quantity 3,358 -2.7%
Value US$60,377
Terrillion Scott Sec'y; Chief Compliance & G.C. Officer
Transaction date
Planned sale
Price
17.98
Quantity 3,090 -5.7%
Value US$55,558
Menzaghi Frederique Ph.D. Chief Scientific Off,SVP-R&D Officer
Transaction date
Planned sale
Price
19.33
Quantity 5,003 -4.3%
Value US$96,708
Terrillion Scott Sec'y; Chief Compliance & G.C. Officer
Transaction date
Planned sale
Price
19.33
Quantity 4,004 -8.3%
Value US$77,397
0.9
CHALMERS DEREK T President & CEO Executive Director
Transaction date
Planned sale
Price
19.33
Quantity 11,729 -1.2%
Value US$226,722
1.3
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
19.33
Quantity 3,372 -11.2%
Value US$65,181
1.3
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
19.73
Quantity 2,000 -7.1%
Value US$39,460
1.3
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
20.12
Quantity 2,000 -6.7%
Value US$40,240
Terrillion Scott Sec'y; Chief Compliance & G.C. Officer
Transaction date
Planned sale
Price
15.30
Quantity 1,946 -4.4%
Value US$29,774
0.9
CHALMERS DEREK T President & CEO Executive Director
Transaction date
Planned sale
Price
15.30
Quantity 6,078 -0.6%
Value US$92,993
Menzaghi Frederique Ph.D. Chief Scientific Off,SVP-R&D Officer
Transaction date
Planned sale
Price
15.30
Quantity 2,812 -2.5%
Value US$43,024
1.3
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
15.30
Quantity 1,298 -4.1%
Value US$19,859
0.9
CHALMERS DEREK T President & CEO Executive Director
Transaction date
Planned sale
Price
16.00
Quantity 5,000 -0.5%
Value US$80,000
1.3
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
15.00
Quantity 2,000 -6.8%
Value US$30,000
0.9
CHALMERS DEREK T President & CEO Executive Director
Transaction date
Sale
Price
14.95
Quantity 5,000 -0.5%
Value US$74,750
0.9
CHALMERS DEREK T President & CEO Executive Director
Transaction date
Sale
Price
15.29
Quantity 7,500 -0.8%
Value US$114,675
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-03-04 2025-02-28 PlS Planned sale
Terrillion Scott

SEC'Y; CHIEF COMPLIANCE & G.C.

Officer
59,770 +31.7%
197.70
US$238,006 		59,770 +31.7% 197.70 US$238,006
2025-03-04 2025-02-28 PlS Planned sale
1.3
Posner Christopher

PRESIDENT AND CEO

Executive Director
58,638 -10.8%
260.90
US$4,598,566 		58,638 -10.8% 260.90 US$4,598,566
2025-02-06 2025-02-04 PlS Planned sale
1.3
Posner Christopher

PRESIDENT AND CEO

Executive Director
16,664 +4.0%
115.74
US$4,735,688 		16,664 +4.0% 115.74 US$4,735,688
2024-11-06 2024-11-04 PlS Planned sale
1.3
Posner Christopher

PRESIDENT AND CEO

Executive Director
3,668 -2.1%
0.29
US$1,064 		3,668 -2.1% 0.29 US$1,064
2024-08-02 2024-08-01 PlS Planned sale
1.3
Posner Christopher

PRESIDENT AND CEO

Executive Director
4,149 -2.3%
0.35
US$1,452 		4,149 -2.3% 0.35 US$1,452
2024-05-06 2024-05-02 PlS Planned sale
1.3
Posner Christopher

PRESIDENT AND CEO

Executive Director
3,936 -2.2%
0.75
US$2,952 		3,936 -2.2% 0.75 US$2,952
2024-04-09 2024-04-05 PlS Planned sale
Terrillion Scott

SEC'Y; CHIEF COMPLIANCE & G.C.

Officer
2,753 -3.0%
0.83
US$2,285 		2,753 -3.0% 0.83 US$2,285
2024-04-09 2024-04-05 PlS Planned sale
1.3
Goncalves Joana

CHIEF MEDICAL OFFICER

Officer
2,753 -4.9%
0.83
US$2,285 		2,753 -4.9% 0.83 US$2,285
2024-03-04 2024-02-29 PlS Planned sale
1.3
Posner Christopher

PRESIDENT AND CEO

Executive Director
5,834 -3.1%
0.89
US$5,192 		5,834 -3.1% 0.89 US$5,192
2024-03-04 2024-02-29 PlS Planned sale
Terrillion Scott

SEC'Y; CHIEF COMPLIANCE & G.C.

Officer
3,293 -3.5%
0.89
US$2,931 		3,293 -3.5% 0.89 US$2,931
2024-03-04 2024-02-29 PlS Planned sale
1.3
Goncalves Joana

CHIEF MEDICAL OFFICER

Officer
3,293 -5.5%
0.89
US$2,931 		3,293 -5.5% 0.89 US$2,931
2024-02-12 2024-02-08 PlS Planned sale
1.3
Posner Christopher

PRESIDENT AND CEO

Executive Director
35,575 -16.0%
0.53
US$18,855 		35,575 -16.0% 0.53 US$18,855
2024-02-05 2024-02-01 PlS Planned sale
1.3
Posner Christopher

PRESIDENT AND CEO

Executive Director
4,981 -2.2%
0.55
US$2,740 		4,981 -2.2% 0.55 US$2,740
2023-11-03 2023-11-02 PlS Planned sale
1.3
Posner Christopher

President and CEO

Executive Director
3,796 -2.3%
1.22
US$4,631 		3,796 -2.3% 1.22 US$4,631
2023-08-04 2023-08-03 PlS Planned sale
1.3
Posner Christopher

President and CEO

Executive Director
4,307 -2.5%
3.07
US$13,222 		4,307 -2.5% 3.07 US$13,222
2023-06-27 2023-06-23 PlS Planned sale
Menzaghi Frederique Ph.D.

Chief Scientific Off,SVP-R&D

Officer
2,993 -1.9%
3.51
US$10,505 		2,993 -1.9% 3.51 US$10,505
2023-06-27 2023-06-23 PlS Planned sale
1.3
Goncalves Joana

Chief Medical Officer

Officer
2,723 -4.8%
3.51
US$9,558 		2,723 -4.8% 3.51 US$9,558
2023-06-27 2023-06-23 PlS Planned sale
Terrillion Scott

Sec'y; Chief Compliance & G.C.

Officer
2,483 -2.7%
3.51
US$8,715 		2,483 -2.7% 3.51 US$8,715
2023-05-09 2023-05-05 PlS Planned sale
1.3
Posner Christopher

President and CEO

Executive Director
3,869 -2.2%
4.40
US$17,024 		3,869 -2.2% 4.40 US$17,024
2023-04-06 2023-04-04 PlS Planned sale
Terrillion Scott

Sec'y; Chief Compliance & G.C.

Officer
2,481 -2.7%
4.91
US$12,182 		2,481 -2.7% 4.91 US$12,182
2023-04-06 2023-04-04 PlS Planned sale
Menzaghi Frederique Ph.D.

Chief Scientific Off,SVP-R&D

Officer
2,733 -1.7%
4.91
US$13,419 		2,733 -1.7% 4.91 US$13,419
2023-04-06 2023-04-04 PlS Planned sale
1.3
Goncalves Joana

Chief Medical Officer

Officer
2,481 -4.2%
4.91
US$12,182 		2,481 -4.2% 4.91 US$12,182
2023-03-07 2023-03-03 PlS Planned sale
Terrillion Scott

Sec'y; Chief Compliance & G.C.

Officer
6,256 -6.3%
9.71
US$60,746 		6,256 -6.3% 9.71 US$60,746
2023-03-07 2023-03-03 PlS Planned sale
1.3
Posner Christopher

President and CEO

Executive Director
5,987 -3.3%
9.71
US$58,134 		5,987 -3.3% 9.71 US$58,134
2023-03-07 2023-03-03 PlS Planned sale
Menzaghi Frederique Ph.D.

Chief Scientific Off,SVP-R&D

Officer
6,802 -4.1%
9.71
US$66,047 		6,802 -4.1% 9.71 US$66,047
2023-03-07 2023-03-03 PlS Planned sale
1.3
Goncalves Joana

Chief Medical Officer

Officer
6,221 -9.6%
9.71
US$60,406 		6,221 -9.6% 9.71 US$60,406
2023-02-17 2023-02-16 PlS Planned sale
1.3
Goncalves Joana

Chief Medical Officer

Officer
2,265 -3.4%
10.20
US$23,103 		2,265 -3.4% 10.20 US$23,103
2024-02-12 2023-02-08 PlS Planned sale
3.3
Maynard Ryan D

CHIEF FINANCIAL OFFICER

Officer
5,488 -40.7%
0.53
US$2,909 		5,488 -40.7% 0.53 US$2,909
2024-02-12 2023-02-08 PlS Planned sale
1.3
Goncalves Joana

CHIEF MEDICAL OFFICER

Officer
7,770 -11.6%
0.53
US$4,118 		7,770 -11.6% 0.53 US$4,118
2024-02-12 2023-02-08 PlS Planned sale
Terrillion Scott

SEC'Y; CHIEF COMPLIANCE & G.C.

Officer
7,770 -7.6%
0.53
US$4,118 		7,770 -7.6% 0.53 US$4,118
2023-02-03 2023-02-02 PlS Planned sale
1.3
Posner Christopher

President and CEO

Executive Director
4,191 -2.2%
11.80
US$49,454 		4,191 -2.2% 11.80 US$49,454
2023-01-19 2023-01-17 PlS Planned sale
1.3
Goncalves Joana

Chief Medical Officer

Officer
2,265 -3.3%
10.81
US$24,485 		2,265 -3.3% 10.81 US$24,485
2023-01-03 2022-12-29 PlS Planned sale
1.3
Goncalves Joana

Chief Medical Officer

Officer
2,265 -3.2%
10.18
US$23,058 		2,265 -3.2% 10.18 US$23,058
2022-12-23 2022-12-21 PlS Planned sale
Menzaghi Frederique Ph.D.

Chief Scientific Off,SVP-R&D

Officer
3,506 -2.1%
11.27
US$39,513 		3,506 -2.1% 11.27 US$39,513
2022-12-23 2022-12-21 PlS Planned sale
Terrillion Scott

Sec'y; Chief Compliance & G.C.

Officer
2,561 -2.5%
11.27
US$28,862 		2,561 -2.5% 11.27 US$28,862
2022-12-23 2022-12-21 PlS Planned sale
1.3
Goncalves Joana

Chief Medical Officer

Officer
2,992 -4.0%
11.27
US$33,720 		2,992 -4.0% 11.27 US$33,720
2022-11-18 2022-11-16 PlS Planned sale
1.3
Posner Christopher

President and CEO

Executive Director
14,470 -7.2%
11.13
US$161,051 		14,470 -7.2% 11.13 US$161,051
2022-09-16 2022-09-14 S Sale
2.0
VOGELBAUM MARTIN
Non-Executive Director
10,800 -19.4%
10.28
US$111,024 		10,800 -19.4% 10.28 US$111,024
2022-07-19 2022-07-15 PlS Planned sale
BAINS HARRISON M JR
Non-Executive Director
7,200 -22.3%
9.05
US$65,160 		7,200 -22.3% 9.05 US$65,160
2022-07-19 2022-07-15 PlS Planned sale
3.3
Ives Jeffrey L.
Non-Executive Director
3,600 -18.9%
9.05
US$32,580 		3,600 -18.9% 9.05 US$32,580
2022-04-05 2022-04-04 PlS Planned sale
1.3
Posner Christopher

President and CEO

Executive Director
2,006 -1.0%
12.67
US$25,416 		2,006 -1.0% 12.67 US$25,416
2022-04-05 2022-04-01 PlS Planned sale
Menzaghi Frederique Ph.D.

Chief Scientific Off,SVP-R&D

Officer
1,784 -1.0%
11.91
US$21,247 		1,784 -1.0% 11.91 US$21,247
2022-04-05 2022-04-01 PlS Planned sale
Terrillion Scott

Sec'y; Chief Compliance & G.C.

Officer
1,642 -1.6%
11.91
US$19,556 		1,642 -1.6% 11.91 US$19,556
2022-04-05 2022-04-01 PlS Planned sale
1.3
Goncalves Joana

Chief Medical Officer

Officer
1,642 -2.1%
11.91
US$19,556 		1,642 -2.1% 11.91 US$19,556
2022-03-04 2022-03-03 PlS Planned sale
Terrillion Scott

Sec'y; Chief Compliance & G.C.

Officer
1,787 -1.7%
11.38
US$20,336 		1,787 -1.7% 11.38 US$20,336
2022-03-04 2022-03-03 PlS Planned sale
Reilly Thomas Charles

Chief Financial Officer

Officer
2,044 -5.1%
11.38
US$23,261 		2,044 -5.1% 11.38 US$23,261
2022-03-01 2022-02-25 PlS Planned sale
Terrillion Scott

Sec'y; Chief Compliance & G.C.

Officer
1,972 -1.9%
10.29
US$20,292 		1,972 -1.9% 10.29 US$20,292
2022-03-01 2022-02-25 PlS Planned sale
Menzaghi Frederique Ph.D.

Chief Scientific Off,SVP-R&D

Officer
2,114 -1.2%
10.29
US$21,753 		2,114 -1.2% 10.29 US$21,753
2022-03-01 2022-02-25 PlS Planned sale
1.3
Goncalves Joana

Chief Medical Officer

Officer
1,972 -2.5%
10.29
US$20,292 		1,972 -2.5% 10.29 US$20,292
2021-11-16 2021-11-12 S Sale
3.3
Ives Jeffrey L.
Non-Executive Director
8,180 -53.2%
16.04
US$131,207 		8,180 -53.2% 16.04 US$131,207
2021-11-03 2021-11-01 PlS Planned sale
1.3
Goncalves Joana

Chief Medical Officer

Officer
1,000 -2.1%
17.15
US$17,150 		1,000 -2.1% 17.15 US$17,150
2021-10-28 2021-10-27 PlS Planned sale
1.3
Goncalves Joana

Chief Medical Officer

Officer
1,000 -2.1%
15.00
US$15,000 		1,000 -2.1% 15.00 US$15,000
2021-09-01 2021-08-30 PlS Planned sale
Terrillion Scott

Sec'y; Chief Compliance & G.C.

Officer
1,759 -2.4%
14.20
US$24,978 		1,759 -2.4% 14.20 US$24,978
2021-06-07 2021-06-07 PlS Planned sale
1.3
Posner Christopher
Non-Executive Director
2,304 -12.5%
13.04
US$30,044 		2,304 -12.5% 13.04 US$30,044
2021-06-07 2021-06-07 PlS Planned sale
2.0
VOGELBAUM MARTIN
Non-Executive Director
8,640 -30.0%
13.05
US$112,752 		8,640 -30.0% 13.05 US$112,752
2021-06-07 2021-06-07 PlS Planned sale
3.3
Ives Jeffrey L.
Non-Executive Director
2,520 -14.1%
13.05
US$32,886 		2,520 -14.1% 13.05 US$32,886
2021-03-24 2021-03-22 PlS Planned sale
1.3
Goncalves Joana

Chief Medical Officer

Officer
3,000 -8.9%
19.65
US$58,950 		3,000 -8.9% 19.65 US$58,950
2021-03-08 2021-03-05 PlS Planned sale
0.9
CHALMERS DEREK T

President & CEO

Executive Director
3,103 -0.3%
17.98
US$55,792 		3,103 -0.3% 17.98 US$55,792
2021-03-08 2021-03-05 PlS Planned sale
1.3
Goncalves Joana

Chief Medical Officer

Officer
3,093 -8.4%
17.98
US$55,612 		3,093 -8.4% 17.98 US$55,612
2021-03-08 2021-03-05 PlS Planned sale
Menzaghi Frederique Ph.D.

Chief Scientific Off,SVP-R&D

Officer
3,358 -2.7%
17.98
US$60,377 		3,358 -2.7% 17.98 US$60,377
2021-03-08 2021-03-05 PlS Planned sale
Terrillion Scott

Sec'y; Chief Compliance & G.C.

Officer
3,090 -5.7%
17.98
US$55,558 		3,090 -5.7% 17.98 US$55,558
2021-02-25 2021-02-25 PlS Planned sale
Menzaghi Frederique Ph.D.

Chief Scientific Off,SVP-R&D

Officer
5,003 -4.3%
19.33
US$96,708 		5,003 -4.3% 19.33 US$96,708
2021-02-25 2021-02-25 PlS Planned sale
Terrillion Scott

Sec'y; Chief Compliance & G.C.

Officer
4,004 -8.3%
19.33
US$77,397 		4,004 -8.3% 19.33 US$77,397
2021-02-25 2021-02-25 PlS Planned sale
0.9
CHALMERS DEREK T

President & CEO

Executive Director
11,729 -1.2%
19.33
US$226,722 		11,729 -1.2% 19.33 US$226,722
2021-02-25 2021-02-25 PlS Planned sale
1.3
Goncalves Joana

Chief Medical Officer

Officer
3,372 -11.2%
19.33
US$65,181 		3,372 -11.2% 19.33 US$65,181
2021-02-24 2021-02-22 PlS Planned sale
1.3
Goncalves Joana

Chief Medical Officer

Officer
2,000 -7.1%
19.73
US$39,460 		2,000 -7.1% 19.73 US$39,460
2021-01-25 2021-01-21 PlS Planned sale
1.3
Goncalves Joana

Chief Medical Officer

Officer
2,000 -6.7%
20.12
US$40,240 		2,000 -6.7% 20.12 US$40,240
2020-12-30 2020-12-30 PlS Planned sale
Terrillion Scott

Sec'y; Chief Compliance & G.C.

Officer
1,946 -4.4%
15.30
US$29,774 		1,946 -4.4% 15.30 US$29,774
2020-12-30 2020-12-30 PlS Planned sale
0.9
CHALMERS DEREK T

President & CEO

Executive Director
6,078 -0.6%
15.30
US$92,993 		6,078 -0.6% 15.30 US$92,993
2020-12-30 2020-12-30 PlS Planned sale
Menzaghi Frederique Ph.D.

Chief Scientific Off,SVP-R&D

Officer
2,812 -2.5%
15.30
US$43,024 		2,812 -2.5% 15.30 US$43,024
2020-12-30 2020-12-30 PlS Planned sale
1.3
Goncalves Joana

Chief Medical Officer

Officer
1,298 -4.1%
15.30
US$19,859 		1,298 -4.1% 15.30 US$19,859
2020-12-29 2020-12-28 PlS Planned sale
0.9
CHALMERS DEREK T

President & CEO

Executive Director
5,000 -0.5%
16.00
US$80,000 		5,000 -0.5% 16.00 US$80,000
2020-12-23 2020-12-21 PlS Planned sale
1.3
Goncalves Joana

Chief Medical Officer

Officer
2,000 -6.8%
15.00
US$30,000 		2,000 -6.8% 15.00 US$30,000
2020-12-18 2020-12-16 S Sale
0.9
CHALMERS DEREK T

President & CEO

Executive Director
5,000 -0.5%
14.95
US$74,750 		5,000 -0.5% 14.95 US$74,750
2020-12-11 2020-12-10 S Sale
0.9
CHALMERS DEREK T

President & CEO

Executive Director
7,500 -0.8%
15.29
US$114,675 		7,500 -0.8% 15.29 US$114,675

See older Tvardi Therapeutics, Inc. insider trades

Plus unlocks the full transaction history.

See localized pricing at checkout
Unlock Tvardi Therapeutics, Inc. history with Plus

Billed monthly · Cancel anytime

Explore more

More insider trading research around Tvardi Therapeutics, Inc.

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America